Federica Guffanti
7PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 26, 2025
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas.Federica Guffanti, Ilaria Mengoli, Francesca Ricci
|Jul 22, 2024
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.Michela Chiappa, Alessandra Decio, Luca Guarrera
|Mar 13, 2024
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.Michela Chiappa, Federica Guffanti, Chiara Grasselli
|Sep 09, 2023
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.Monica Ganzinelli, Federica Guffanti, Anna Ianza
|Apr 12, 2022
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells.Michela Chiappa, Federica Guffanti, Martina Anselmi
|Aug 28, 2020
Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts.Federica Guffanti, Maria Francesca Alvisi, Elisa Caiola
Pageof 2
Frequent Collaborators
5 joint publications
Giovanna Damia
4 joint publications
Michela Chiappa
2 joint publications
Francesca Ricci
2 joint publications
Maya Ridinger
2 joint publications
Simone Canesi
1 joint publications
Luc Furic
1 joint publications
Massimo Broggini
1 joint publications
Marco Falasca
1 joint publications
Maria Francesca Alvisi
1 joint publications
Robert Fruscio
